Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.02M Sell
3,261
-26
-0.8% -$7.68K 0.23% 72
2024
Q4
$857K Buy
3,287
+419
+15% +$124K 0.2% 82
2024
Q3
$924K Buy
2,868
+17
+0.6% +$5.56K 0.34% 43
2024
Q2
$891K Sell
2,851
-22
-0.8% -$6.46K 0.37% 40
2024
Q1
$817K Buy
2,873
+116
+4% +$33.9K 0.24% 72
2023
Q4
$794K Buy
2,757
+5
+0.2% +$1.36K 0.25% 73
2023
Q3
$740K Buy
+2,752
New +$687K 0.26% 71
2023
Q2
Sell
-2,635
Closed -$637K 95
2023
Q1
$637K Buy
2,635
+4
+0.2% +$982 0.25% 73
2022
Q4
$693K Buy
+2,631
New +$705K 0.31% 64

Other funds holding AMGN

Delta Financial Group's AMGN Position: Q1 2025 in Review

Delta Financial Group reduced its Amgen (AMGN) stake by 0.79% in Q1 2025, selling an estimated $7.68K and leaving 3,261 shares worth $1.02M. The position accounts for 0.23% of the portfolio, ranked #72.

Delta Financial Group first reported a position in AMGN in Q4 2022 and has held it in 9 quarters since. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Delta Financial Group held 3,261 shares of Amgen worth $1.02M as of Q1 2025.
  • Delta Financial Group sold 26 Amgen shares in Q1 2025, an estimated $7.68K.
  • Amgen made up 0.23% of Delta Financial Group's portfolio in Q1 2025, its #72 holding.
  • Delta Financial Group first reported a position in Amgen in Q4 2022 and has held it in 9 quarters since.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.